SK Life Science Launches Epilepsy Care Platform

SK Life Science, Inc. has launched Epilepsy Connect, a new digital platform designed to support and empower advanced practice providers (APPs) in managing epilepsy care. This initiative aims to improve the quality and efficiency of care for patients with epilepsy by providing specialized tools and resources for healthcare professionals. The platform represents a significant step in leveraging digital health solutions to enhance patient outcomes and streamline clinical workflows within the neurology sector.